Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder cancer in the 21st century. J Oncol. 2015;2015:967472.
Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211–7.
Aloia TA, Jarufe N, Javle M, Maithel SK, Roa JC, Adsay V, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681–90.
Liz J, Esteller M. Lncrnas and micrornas with a role in cancer development. Biochim Biophys Acta. 2016;1859(1):169–76.
Managadze D, Lobkovsky AE, Wolf YI, Shabalina SA, Rogozin IB, Koonin EV. The vast, conserved mammalian lincrnome. PLoS Comput Biol. 2013;9(2):e1002917.
Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD, YY Qin, et al. Long non-coding RNA HOTAIR, a c-myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer. 2014;13:156.
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W, et al. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015;6:e1583.
Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding Q, et al. Malat1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther. 2014;15(6):806–14.
Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, et al. Endogenous miRNA sponge lincRNA-RoR regulates oct4, Nanog, and sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013;25(1):69–80.
Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, et al. Large intergenic non-coding rna-ror modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010;42(12):1113–7.
Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long noncoding RNA RoR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio.2014;4:458–67.
Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y, et al. LincRNA-RoR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 2014;5:e1287.
Mitra A, Mishra L, Li S. Emt, ctcs and cscs in tumor relapse and drugresistance. Oncotarget. 2015;6(13):10697–711.
Brivio S, Cadamuro M, Fabris L, Strazzabosco M. Epithelial-to-mesenchymal transition and cancer invasiveness: what can we learn from cholangiocarcinoma? J Clin Med. 2015;4(12):2028–41.
Creighton CJ, Gibbons D, Kurie JM. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res. 2013;5:187–95.
Peinado H, Olmeda D, Cano A. Snail, zeb and bhlh factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7(6):415–28.
Guil S, Esteller M. RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem Sci. 2015;40(5):248–56.
Takahashi K, Yan Ik, Haga H, Patel T. Modulation of hypoxia-signaling pathways by extracellular lincror. J Cell Sci. 2014;127:1585–94.
Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q. LincRNA-RoR and mir-145 regulate invasion in triple-negative breast cancer via targeting arf6. Mol Cancer Res. 2015;13(2):330–8.
Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T, et al. Ror functions as a cerna to regulate nanog expression by sponging mir-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 2016;7(2):1608–18.
Feng S, Yao J, Chen Y, Geng P, Zhang H, Ma X, etal. Expression and functional role of reprogrammingrelated long noncoding RNA (lincRNA-RoR) in glioma. J Mol Neurosci. 2015;56(3):623–30.